opc 12759 has been researched along with Insulin Resistance in 1 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
Excerpt | Relevance | Reference |
---|---|---|
"Obesity is a medical term used to describe an over-accumulation of adipose tissue." | 1.72 | Rebamipide treatment ameliorates obesity phenotype by regulation of immune cells and adipocytes. ( Cho, KH; Cho, ML; Choi, J; Jhun, J; Jung, YJ; Kim, SY; Min, JK; Moon, J; Na, HS; Song, KY, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Jhun, J | 1 |
Moon, J | 1 |
Kim, SY | 1 |
Cho, KH | 1 |
Na, HS | 1 |
Choi, J | 1 |
Jung, YJ | 1 |
Song, KY | 1 |
Min, JK | 1 |
Cho, ML | 1 |
1 other study available for opc 12759 and Insulin Resistance
Article | Year |
---|---|
Rebamipide treatment ameliorates obesity phenotype by regulation of immune cells and adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Diet, High-Fat; Inflammation; Insulin Resistance; | 2022 |